EKSO Q2 2018 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$30M

Q2 2018 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$3M+58.9% YoY

Gross Profit

$967,00032.6% margin

Operating Income

-$7M-242.2% margin

Net Income

-$8M-268.9% margin

EPS (Diluted)

$-1.97

QoQ Revenue Growth

+17.8%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$464,000

Balance Sheet

Total Assets

$23M

Total Liabilities

$16M

Stockholders' Equity

$8M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+58.9%
Gross Profit	$967,000	$396,000	+144.2%
Operating Income	-$7M	-$8M	+15.1%
Net Income	-$8M	-$6M	-44.9%

Revenue Segments

Medical

$2M81%

Industrial

$557,00019%

Engineering Services Segment

$11,0000%

Geographic Segments

United States

$2M60%

All Other

$1M40%